The new method relies on methyl groups, small chemical tags attached to DNA that regulate whether genes are on or off. This ...

The global cell therapy technologies market is set to grow from USD 4.41 billion in 2025 to USD 7.91 billion by 2030, ...

A research team has discovered an enhanced CRISPR gene-editing system that could enable targeted delivery inside the human ...

A compact Cas12f nuclease shows high editing efficiency in human cells, with structural insights enabling an engineered variant potentially suited for future AAV‑compatible delivery.

“While recent single-cell multiomics studies and CRISPR screens in murine NK cells have expanded our understanding, actionable genomic targets in primary human NK cells have remained largely ...

Scientists have taken an important step toward a gene therapy that could one day turn off the extra genetic material that ...

There are plenty of reasons, though, to be bullish on the stock, not the least of which is its improved cash position. The ...

Stem cells hold a tremendous amount of research promise. At one time, obtaining them seemed to be a nearly insurmountable challenge, until a process was invented by Gladstone Senior Investigator ...

BOSTON & ZUG, Switzerland--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) announced today that the U.S. Food and Drug Administration (FDA) ...

Most gene-editing tools are blind to context. Point them at a DNA sequence and they cut, whether that sequence sits inside a ...